CytomX Therapeutics, Inc. ( CTMX) - Key Metrics
CTMX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.09 | -$0.08 | -$0.08 |
| 2026Q1 | $0.06 | -$0.10 | -$0.14 | -$0.14 |
| 2025Q4 | $0 | -$0.16 | -$0.14 | -$0.14 |
| 2025Q3 | $0.04 | -$0.09 | -$0.09 | -$0.09 |
| 2025Q2 | $0.14 | $0 | -$0.12 | -$0.12 |
CTMX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.42 |
| 2026Q1 | 0% | -11.75 |
| 2025Q4 | 0% | -6.26 |
| 2025Q3 | 0% | -8.86 |
| 2025Q2 | 0% | -472.92 |
CTMX
Price: $3.36
52 week price:
Earnings Per Share: -0.57 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 865300
Ebitda: -10.5 millionMarket Capitalization: 760.5 million